Digital pathology involves the digitization, visualization, analysis, and sharing of pathology images using specialized hardware and software. Whole-slide imaging scanners convert traditional glass slides into digital images that can be examined, stored, and accessed electronically. These technologies support disease diagnosis, research activities, and collaboration among pathologists. Hospitals, clinical laboratories, pharmaceutical companies, and research institutions are increasingly incorporating digital solutions into their pathology operations.
According to Fortune Business Insights, the global digital pathology market size was valued at USD 1.3 billion in 2025 and is projected to grow from USD 1.47 billion in 2026 to USD 5.75 billion by 2034, exhibiting a CAGR of 18.56% during the forecast period. North America dominated the market with a share of 36.74% in 2025. The increasing adoption of digital diagnostic technologies, rising demand for efficient pathology workflows, and advancements in artificial intelligence-based image analysis are contributing to the growth of the global digital pathology market.
Major companies operating in the digital pathology market are focusing on product innovation, advanced imaging technologies, and integrated pathology solutions. Key companies include:
Market Driver – Increasing demand for efficient diagnostic workflows: The growing volume of pathology tests and the need for timely disease diagnosis are encouraging healthcare providers to adopt digital pathology solutions. Digital slide imaging allows pathologists to review and share specimens electronically, supporting remote consultation and coordination across healthcare facilities. The increasing burden of chronic diseases and cancer is also contributing to the demand for advanced diagnostic technologies.
Market Driver – Integration of artificial intelligence: AI-based image analysis is transforming digital pathology by supporting cellular detection, tissue classification, biomarker quantification, and image assessment. These capabilities can assist pathologists in analyzing complex images and managing workloads. The development of customized platforms and computational tools is supporting market expansion.
Market Restraint – High installation costs: Digital pathology systems require substantial investment in scanners, software, storage infrastructure, and staff training. Integration with existing laboratory systems can further increase implementation expenses. These costs may limit adoption among smaller laboratories and healthcare facilities with restricted budgets.
Market Opportunity – Remote pathology and research collaboration: Digital platforms provide opportunities for remote slide review, specialist consultation, and collaboration among geographically distributed teams. Pharmaceutical research organizations can also use digital pathology for drug discovery, biomarker assessment, and translational studies. These applications may support broader adoption across clinical and research environments.
The competitive landscape is characterized by the presence of medical technology companies, imaging solution providers, and pathology software developers. Companies are investing in advanced scanners, image management systems, and AI-based analytical platforms to strengthen their product portfolios. Strategic partnerships and technological developments are supporting the integration of digital pathology into existing laboratory workflows.